Venture Capital in USA – e.Lilly Ventures

Lilly Ventures is the venture capital arm of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. Their primary goal is to facilitate the success of companies in their areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has three funds under management. e.Lilly Venture Fund, a $50 million fund founded in January 2001, targets investments in start-up companies with innovative network technologies that promise to have a transformational impact on the current pharmaceutical business model. Lilly BioVenture Fund, a $75 million fund founded in September 2001, targets investments in biotechnology companies with pioneering drug discovery and development technologies and novel therapies. © e.Lilly Ventures